ABOUT THIS EPISODE
00:00 Introduction and Overview of Caristo Diagnostics
09:08 The Technology Behind Carry Heart
18:00 Clinical Implications and Risk Assessment
27:27 Actionable Steps for Patients
30:34 Optimizing Cardiovascular Drug Dosing
32:31 AI in Cardiovascular Medicine
33:50 Leveraging Historical Data for Risk Prediction
36:25 AI's Role in Molecular Pathway Analysis
39:03 GLP-1 and Cardiovascular Outcomes
41:56 Targeted Therapies in Cardiovascular Treatment
42:45 Building Trust in New Technologies
49:16 Regulatory Approvals and Future Prospects
54:15 Expanding Applications Beyond Cardiology
57:16 Looking Ahead: The Future of Caristo Diagnostics
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of The Harry Glorikian Show.
OTHER EPISODES IN THIS PODCAST
One of the most amazing successes in the battle against cancer over the last two decades has been the introduction of antibody drugs that harness the body’s own immune system to kill tumor cells. Finding those drugs may sound like a biology problem rather than a machine learning or a big-data probl…
If you look back at all the health-tech and drug development companies Harry has hosted on the show, an interesting pattern starts to emerge: a very large number of those companies have gone on to enormous growth and success in their markets. It could be that being on the podcast is like a catapult…
Investors and companies in the life science industry have been betting a lot of money over the last few years on a single idea: that computation will help us get a lot better at developing new drugs. But the word “computation” covers a pretty broad range of techniques. And the reason that there are…
If you learned that radiologists looking at CT scans for the traditional signs of coronary artery disease catch only 20 percent of the people who actually have a high risk of a heart attack, and if you learned that there’s a new AI-based test that can catch subtle signs of inflammation in the other…
Generative AI is going to change how we do things across the entire economy, including the fields Harry covers on the show, namely healthcare delivery, drug discovery, and drug development. But we’re still just starting to figure out exactly how it’s going to change things. For example, AI is alrea…
Disclaimer: The podcast and artwork embedded on this page are from Harry Glorikian, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
